Table 3.
Time to first negative T. vaginalis NAAT test by selected variables (n=89)
| Median (min-max range) [IQR] |
Log-Rank (for comparison) |
|
|---|---|---|
| Metronidazole Dose | ||
| Single | 9(6-28) [7-14] | 0.04 |
| Multi | 7(7-20) [7-10] | |
| Douching* | ||
| Yes | 8 (6, 22) [7-14] | 0.87 |
| No | 8 (7, 28) [7-12] | |
| Baseline Symptoms** | ||
| Yes | 8 (6-28) [7-12] | 0.81 |
| No | 8 (6-19) [7-13] | |
| History of T. vaginalis | ||
| Yes | 8 (6-28) [7-11] | 0.58 |
| No | 8 (6-23) [7-14] | |
| Bacterial Vaginosis | ||
| Yes | 8 (6-23) [7-12] | 0.30 |
| No | 8 (6-34) [7-14] |
Douching defined as any douching in the 30 months prior to the baseline visit.
Baseline symptom is defined as having any one (or more) of the following: vaginal discharge, vaginal odor, vaginal itching or irritation, pain while urinating, pelvic pain, or other vaginal complaints.